ArticleJACC. Advances2025

Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a): A Meta-Analysis and Meta-Regression of Randomized Controlled Trials.

Frederick Berro Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.